Editorial
|
|
|
The American Psychiatric Association fails to ensure its independence
|
|
|
New Products
|
|
|
Active against hepatitis C virus, but evaluation is incomplete
|
|
|
|
|
|
|
|
In basal cell carcinoma: too many unknowns
|
|
|
|
|
|
Still authorised despite an unfavourable opinion of the European pharmacovigilance committee
|
|
|
Adverse Effects
|
|
|
Effects on fertility unclear
|
|
|
|
|
|
Data from pharmacovigilance review
|
|
|
|
|
|
Sometimes accompanied by deafness
|
|
|
|
|
|
Oral gel and buccal tablets
|
|
|
|
|
|
Consistent with other data
|
|
|
|
|
|
Renal impairment is a risk factor
|
|
|
|
|
|
Patients should be informed
|
|
|
|
|
|
|
Yet another adverse effect
|
|
|
|
|
|
Reviews
|
|
|
The essentials of first-line management
|
|
|
|
|
|
Reduced symptoms, less need for surgery
|
|
|
|
|
|
Harm-benefit balance appears unfavourable in this situation
|
|
|
Outlook
|
|
|
A diverse panel of reviewers
|
|
|
|
|
|
A worldwide trend affecting even the wealthiest countries
|
|
|
|